Clinical trial
Scale Validation Study for Prediction of Relapse and Short Term…
NCT00358852 · Janssen-Cilag, S.A., Industry · Completed
Key facts
| NCT number | NCT00358852 |
|---|---|
| Title | Scale Validation Study for Prediction of Relapse and Short Term Rehospitalization in Patients With Schizophrenia |
| Official title | Scale Validation of Prediction of Relapse and Rehospitalization Short Term in Patients With Schizophrenia |
| Acronym | PRE-COG |
| Lead sponsor | Janssen-Cilag, S.A., Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Schizophrenia |
| Intervention type | Other |
| Interventions | No intervention |
| Enrollment | 2,339 |
| Start date | Aug 1, 2006 |
| Primary completion | Sep 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Aug 1, 2006 |
| Last update posted | Mar 19, 2014 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: